|
Material Transfer Agreement (MTA)Materials are typically the starting point, or at least play a crucial role in creating new innovations. As a result, the use of materials is potentially very valuable for generating novel intellectual property. The MTA defines the intellectual property rights of the provider and the recipient with respect to the materials and any derivatives. Biological materials, such as reagents, cell lines, plasmids, and vectors, are the most frequently transferred materials, but MTAs may also be used for other types of materials, such as chemical compounds and even some types of software. On this page you will find MTAs for commonly requested materials. The page is organized by Principal Investigator (PI). Because LANL is a contractor of the U.S. government, the Laboratory must follow rules and regulations mandated by the Department of Energy. These regulations stipulate the following:
Available Materials (by PI)
Green Fluorescent Protein (GFP) Materials LANL has teamed up with a local biotechnology company to distribute many of the GFP components. Beginning November 15, 2008, non-commercial entities interested in obtaining LANL's in vitro Split GFP, Superfolder GFP, or a mammalian codon-optimized version of the in vivo Split GFP plasmids will need to obtain the materials through our partner, Theranostic, Inc. All commercial parties interested in licensing these materials should visit LANL's GFP licensing page.
|
